CLINICAL TRIALS PROFILE FOR EPIPEN E Z PEN

All Clinical Trials for EPIPEN E Z PEN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00434421 ↗	Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma	Completed	Inner-City Asthma Consortium	Phase 1	2007-02-01	Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00434421 ↗	Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	2007-02-01	Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	Medical University of South Carolina	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗	Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3	2009-06-01	The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.

Clinical Trial Conditions for EPIPEN E Z PEN

Condition Name

Condition Name for EPIPEN E Z PEN
Intervention	Trials
Anaphylaxis	2
Scoliosis	1
Dermatologic Surgery	1
Status Epilepticus	1

Condition MeSH

Condition MeSH for EPIPEN E Z PEN
Intervention	Trials
Anaphylaxis	2
Rhinitis, Allergic	2
Rhinitis	2
Multiple Sclerosis	1

Clinical Trial Locations for EPIPEN E Z PEN

Trials by Country

Trials by Country for EPIPEN E Z PEN
Location	Trials
United States	40
Croatia	1
Ukraine	1
Sweden	1
Serbia	1

Trials by US State

Trials by US State for EPIPEN E Z PEN
Location	Trials
Maryland	4
New York	3
Michigan	2
Kentucky	2
Georgia	2

Clinical Trial Progress for EPIPEN E Z PEN

Clinical Trial Phase

Clinical Trial Phase for EPIPEN E Z PEN
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	3
Phase 2/Phase 3	1

Clinical Trial Status

Clinical Trial Status for EPIPEN E Z PEN
Clinical Trial Phase	Trials
Completed	8
Unknown status	1
Withdrawn	1

Clinical Trial Sponsors for EPIPEN E Z PEN

Sponsor Name

Sponsor Name for EPIPEN E Z PEN
Sponsor	Trials
National Institute of Allergy and Infectious Diseases (NIAID)	2
Merck Sharp & Dohme Corp.	1
Arthroplasty Foundation, Inc.	1

Sponsor Type

Sponsor Type for EPIPEN E Z PEN
Sponsor	Trials
Other	10
Industry	5
NIH	3